About the Company
We do not have any company description for FENNEC PHARMACEUTICALS INC. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on FENNEC PHARMACEUTICALS INC.
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
NasdaqCM:FENC 1 Year Share Price vs Fair Value Explore Fennec Pharmaceuticals's Fair Values from the Community ...
Fennec Pharmaceuticals Reports Second Quarter 2025 Financial Results And Provides Business Update
Achieved Second Quarter 2025 Total Net Revenues of $9.7 Million ~ ~ Double Digit New Accounts in the Second Quarter of 2025, Including Notable Quarter-Over-Quarter Growth in Both Large Community ...
Fennec Pharmaceuticals Reports Strong Q2 2025 Results and Expands Global Reach
Detailed price information for Fennec Pharmaceuticals Inc (FENC-Q) from The Globe and Mail including charting and trades.
Intech Investment Management LLC Acquires Shares of 10,988 Fennec ...
Intech Investment Management LLC bought a new position in Fennec Pharmaceuticals Inc (NASDAQ:FENC – Free Report) during the 4th quarter, according to the company in its most recent disclosure ...
Fennec Pharmaceuticals Inc. (FENC) Q1 2025 Earnings Call Transcript
Fennec Pharmaceuticals Inc. (NASDAQ: FENC) Q1 2025 Earnings Conference Call May 13, 2025 8:30 AM ET Company Participants Robert Andrade - Chief Financial Officer ...
Fennec Pharmaceuticals Inc (RV41.MU) - Yahoo Finance
Fennec Announces Results of Annual Meeting RESEARCH TRIANGLE PARK, N.C., June 03, 2025 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (the “Company”) (NASDAQ:FENC) (TSX:FRX) today announced that the ...
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q2 2023 Earnings Call ...
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q2 2023 Earnings Call Transcript Published on August 10, 2023 at 12:53 pm by Insider Monkey Transcripts in News, Transcripts Page 1 of 2 Next >> ...
Fennec Pharmaceuticals to Report First Quarter 2025 Financial ... - Nasdaq
--Fennec Pharmaceuticals Inc., a commercial stage specialty pharmaceutical company, today announced that the Company will release its first quarter 2025 financial results before the opening of the ...
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q3 2024 Earnings Call ...
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q3 2024 Earnings Call Transcript Published on November 11, 2024 at 8:30 am by Insider Monkey Transcripts in News, Transcripts ...
Fennec Pharmaceuticals Analyst Ratings and Price Targets | NASDAQ:FENC ...
Fennec Pharmaceuticals Inc has a consensus price target of $14.33 based on the ratings of 6 analysts. The high is $19 issued by Wedbush on September 26, 2022.
Fennec Pharmaceuticals Inc.: Fennec Pharmaceuticals Reports Second Quarter 2025 Financial Results And Provides Business Update
Achieved Second Quarter 2025 Total Net Revenues of $9.7 Million ~ ~ Double Digit New Accounts in the Second Quarter of 2025, Including Notable Quarter-Over-Quarter Growth in Both Large Community Pract ...
Fennec Pharmaceuticals Inc. (FENC) Q2 2023 Earnings Call Transcript
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q2 2023 Earnings Conference Call August 3, 2023 8:30 AM ETCompany ParticipantsRobert Andrade - Chief Financial ...
Similar Companies
Loading the latest forecasts...